Elemental arsenic entered the cerebrospinal fluid during oral arsenic trioxide treatment of meningeal relapse of acute promyelocytic leukemia

被引：26
|
作者：
Au, WY [1 ]
Tam, S [1 ]
Fong, BM [1 ]
Kwong, YL [1 ]
机构：
[1] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
来源：
BLOOD | 2006年 / 107卷 / 07期
关键词：
D O I：
10.1182/blood-2005-10-4175
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3012 / 3013
页数：2
相关论文
共 50 条
  • [31] Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia
    H. Agis
    A. Weltermann
    G. Mitterbauer
    R. Thalhammer
    M. Edelhäuser
    H. L. Seewann
    P. Valent
    K. Lechner
    C. Fonatsch
    K. Geissler
    Annals of Hematology, 1999, 78 : 329 - 332
  • [32] Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia
    Agis, H
    Weltermann, A
    Mitterbauer, G
    Thalhammer, R
    Edelhäuser, M
    Seewann, HL
    Valent, P
    Lechner, K
    Fonatsch, C
    Geissler, K
    ANNALS OF HEMATOLOGY, 1999, 78 (07) : 329 - 332
  • [33] Oral arsenic trioxide for relapsed acute promyelocytic leukemia in pediatric patients
    Au, Wing Y.
    Li, Chi-Kong
    Lee, Vincent
    Yuen, Hui Leung
    Yau, Jeffrey
    Chan, Godfrey C. F.
    Ha, Shau-yin
    Kwong, Yok-lam
    PEDIATRIC BLOOD & CANCER, 2012, 58 (04) : 630 - 632
  • [34] Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment
    Baowei Chen
    Fenglin Cao
    Chungang Yuan
    Xiufen Lu
    Shengwen Shen
    Jin Zhou
    X. Chris Le
    Analytical and Bioanalytical Chemistry, 2013, 405 : 1903 - 1911
  • [35] Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment
    Chen, Baowei
    Cao, Fenglin
    Yuan, Chungang
    Lu, Xiufen
    Shen, Shengwen
    Zhou, Jin
    Le, X. Chris
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2013, 405 (06) : 1903 - 1911
  • [36] Herpes zoster during arsenic trioxide therapy for acute promyelocytic leukemia
    Freyer, Craig W.
    Peterson, Chelsea E.
    Man, Yun
    Przespolewski, Amanda
    Baron, Jeffrey
    Luger, Selina M.
    LEUKEMIA & LYMPHOMA, 2021, 62 (03) : 696 - 702
  • [37] Impact of Arsenic Trioxide in the Treatment of Higher Risk Acute Promyelocytic Leukemia
    Da Rocha, Audrey
    Cassinat, Bruno
    Heiblig, Mael
    Recher, Christian
    Bertoli, Sarah
    Bonmati, Caroline
    Roth-Guepin, Gabrielle
    Zilliox, Anne
    Laloi, Marie
    Hunault, Mathilde
    Berthon, Celine
    Duployez, Nicolas
    Willekens, Christophe
    Hernanz, Maria Pilar Gallego
    Ochmann, Marlene
    Cluzeau, Thomas
    Chermat, Fatiha
    Caulier, Alexis
    Raffoux, Emmanuel
    Fenaux, Pierre
    Marolleau, Jean Pierre
    Ades, Lionel
    Lebon, Delphine
    BLOOD, 2023, 142
  • [38] Arsenic trioxide as first-line treatment for acute promyelocytic leukemia
    Leu, Lily
    Mohassel, Leila
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (21) : 1913 - 1918
  • [39] Successful treatment of a case of relapsed acute promyelocytic leukemia with arsenic trioxide
    Hirayama, Y
    Koyama, R
    Nagai, T
    Ohta, H
    Kondo, A
    Ishikawa, K
    Ishitani, K
    Matsunaga, T
    Sakamaki, S
    Niitsu, Y
    INTERNAL MEDICINE, 2001, 40 (11) : 1136 - 1139
  • [40] Molecular basis for the treatment of acute promyelocytic leukemia with ATRA and arsenic trioxide
    Chen, Z
    Chen, SJ
    Wang, ZY
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 20 - 20
12345